Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11.

Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, Bermingham A, McLean E, Zhao H, Bolotin S, Dar O, Watson JM, Zambon M.

Euro Surveill. 2011 Jan 6;16(1). pii: 19760.

2.

Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.

Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, Shaw R, Lin C, Yap J, Cook AR, Tan BH, Loh JP, Barkham T, Chow VT, Lin RT, Leo YS.

PLoS One. 2010 Aug 30;5(8):e12474. doi: 10.1371/journal.pone.0012474.

3.

Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.

Hung IF, To KK, Lee CK, Lin CK, Chan JF, Tse H, Cheng VC, Chen H, Ho PL, Tse CW, Ng TK, Que TL, Chan KH, Yuen KY.

Clin Infect Dis. 2010 Aug 1;51(3):274-9. doi: 10.1086/653940.

PMID:
20575664
4.

Comparative epidemiology of pandemic and seasonal influenza A in households.

Cowling BJ, Chan KH, Fang VJ, Lau LLH, So HC, Fung ROP, Ma ESK, Kwong ASK, Chan CW, Tsui WWS, Ngai HY, Chu DWS, Lee PWY, Chiu MC, Leung GM, Peiris JSM.

N Engl J Med. 2010 Jun 10;362(23):2175-2184. doi: 10.1056/NEJMoa0911530.

5.

Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus.

[No authors listed]

Wkly Epidemiol Rec. 2010 Jun 11;85(24):229-35. English, French. No abstract available.

6.

Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore.

Tang JW, Tambyah PA, Wilder-Smith A, Puong KY, Shaw R, Barr IG, Chan KP.

Emerg Infect Dis. 2010 May;16(5):874-6. doi: 10.3201/eid1605.091678. No abstract available.

7.

2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.

Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, Yap J, Cui L, Cook AR, Laurie K, Tan LW, Tan BH, Loh J, Shaw R, Durrant C, Chow VT, Kelso A, Chia KS, Leo YS.

JAMA. 2010 Apr 14;303(14):1383-91. doi: 10.1001/jama.2010.404.

PMID:
20388894
8.

Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009.

Dawood FS, Hope KG, Durrheim DN, Givney R, Fry AM, Dalton CB.

PLoS One. 2010 Mar 25;5(3):e9880. doi: 10.1371/journal.pone.0009880.

9.

Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA.

Science. 2010 Apr 16;328(5976):357-60. doi: 10.1126/science.1186430. Epub 2010 Mar 25.

10.

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.

Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, Caporali MG, Ranghiasci A, Lapini G, Piccirella S, Salmaso S, Montomoli E.

Vaccine. 2010 Apr 30;28(20):3558-62. doi: 10.1016/j.vaccine.2010.03.006. Epub 2010 Mar 20.

PMID:
20307592
11.

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza.

Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B.

Version 2. PLoS Curr. 2010 Feb 24 [revised 2010 Apr 25];2:RRN1148.

12.

High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.

Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, Davidkin I, Ziegler T, Julkunen I.

Euro Surveill. 2010 Feb 4;15(5). pii: 19478.

13.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M.

Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.

PMID:
20096450
14.

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L.

Emerg Infect Dis. 2009 Dec;15(12):2004-7. doi: 10.3201/eid1512.091413.

15.

Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China.

Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong MD, Farrar J, Riley S, Smith GJ, Guan Y.

Emerg Infect Dis. 2009 Nov;15(11):1849-50. doi: 10.3201/eid1511.090868. No abstract available.

16.

Reproducibility of serologic assays for influenza virus A (H5N1).

Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM.

Emerg Infect Dis. 2009 Aug;15(8):1252-9. doi: 10.3201/eid1508.081754.

17.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.

18.

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.

Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y.

Nature. 2009 Aug 20;460(7258):1021-5. doi: 10.1038/nature08260.

19.

Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Jun 5;58(21):585-9.

20.

Managing and reducing uncertainty in an emerging influenza pandemic.

Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM.

N Engl J Med. 2009 Jul 9;361(2):112-5. doi: 10.1056/NEJMp0904380. Epub 2009 May 27. No abstract available.

Supplemental Content

Support Center